SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-18-019566
Filing Date
2018-03-22
Accepted
2018-03-22 16:05:39
Documents
10
Period of Report
2018-03-21

Document Format Files

Seq Description Document Type Size
1 6-K a18-8713_16k.htm 6-K 19879
2 EX-1 a18-8713_1ex1.htm EX-1 2142119
3 EX-2 a18-8713_1ex2.htm EX-2 76446
4 EX-3 a18-8713_1ex3.htm EX-3 51841
5 GRAPHIC g87131ka13i001.jpg GRAPHIC 21527
6 GRAPHIC g87131ka11i001.jpg GRAPHIC 39797
7 GRAPHIC g87131ka11i002.jpg GRAPHIC 14807
8 GRAPHIC g87131ka05i001.jpg GRAPHIC 34097
9 GRAPHIC g87131ka15i001.jpg GRAPHIC 5943
10 GRAPHIC g87131kc01i001.jpg GRAPHIC 4153
  Complete submission text file 0001104659-18-019566.txt   2457820
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38067 | Film No.: 18706984
SIC: 2834 Pharmaceutical Preparations